U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.2644A>G (p.Ile882Val) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003283513.2

Allele description [Variation Report for NM_000051.4(ATM):c.2644A>G (p.Ile882Val)]

NM_000051.4(ATM):c.2644A>G (p.Ile882Val)

Gene:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.2644A>G (p.Ile882Val)
HGVS:
  • NC_000011.10:g.108268415A>G
  • NG_009830.1:g.50584A>G
  • NM_000051.4:c.2644A>GMANE SELECT
  • NM_001351834.2:c.2644A>G
  • NP_000042.3:p.Ile882Val
  • NP_000042.3:p.Ile882Val
  • NP_001338763.1:p.Ile882Val
  • LRG_135t1:c.2644A>G
  • LRG_135:g.50584A>G
  • LRG_135p1:p.Ile882Val
  • NC_000011.9:g.108139142A>G
  • NM_000051.3:c.2644A>G
Protein change:
I882V
Molecular consequence:
  • NM_000051.4:c.2644A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001351834.2:c.2644A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004007179Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Apr 7, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Rare germline variants in ATM are associated with chronic lymphocytic leukemia.

Tiao G, Improgo MR, Kasar S, Poh W, Kamburov A, Landau DA, Tausch E, Taylor-Weiner A, Cibulskis C, Bahl S, Fernandes SM, Hoang K, Rheinbay E, Kim HT, Bahlo J, Robrecht S, Fischer K, Hallek M, Gabriel S, Lander ES, Stilgenbauer S, Wu CJ, et al.

Leukemia. 2017 Oct;31(10):2244-2247. doi: 10.1038/leu.2017.201. Epub 2017 Jun 27. No abstract available.

PubMed [citation]
PMID:
28652578
PMCID:
PMC5628120

Details of each submission

From Ambry Genetics, SCV004007179.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.I882V variant (also known as c.2644A>G), located in coding exon 17 of the ATM gene, results from an A to G substitution at nucleotide position 2644. The isoleucine at codon 882 is replaced by valine, an amino acid with highly similar properties. This alteration has been reported in normal population control subjects (Tiao G et al. Leukemia, 2017 Oct;31:2244-2247). This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024